Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.

Adverse mortality effect of central sympathetic inhibition with sustained-release moxonidine in patients with heart failure (MOXCON).

Cohn JN, Pfeffer MA, Rouleau J, Sharpe N, Swedberg K, Straub M, Wiltse C, Wright TJ; MOXCON Investigators.

Eur J Heart Fail. 2003 Oct;5(5):659-67.

2.
3.

Pharmacological properties of the central antihypertensive agent, moxonidine.

Edwards LP, Brown-Bryan TA, McLean L, Ernsberger P.

Cardiovasc Ther. 2012 Aug;30(4):199-208. doi: 10.1111/j.1755-5922.2011.00268.x. Epub 2011 Apr 5. Review.

PMID:
21884003
4.

Pharmacology and clinical use of moxonidine, a new centrally acting sympatholytic antihypertensive agent.

Prichard BN, Owens CW, Graham BR.

J Hum Hypertens. 1997 Aug;11 Suppl 1:S29-45. Review.

PMID:
9321737
5.
6.

Moxonidine: a new and versatile antihypertensive.

Messerli F.

J Cardiovasc Pharmacol. 2000;35(7 Suppl 4):S53-6. Review.

PMID:
11346219
7.

Abnormalities of peripheral sympathetic nervous system control in congestive heart failure.

Cohn JN.

Circulation. 1990 Aug;82(2 Suppl):I59-67. Review.

PMID:
1973641
8.

Moxonidine: some controversy.

Doggrell SA.

Expert Opin Pharmacother. 2001 Feb;2(2):337-50. Review.

PMID:
11336590
9.

Why imidazoline receptor modulator in the treatment of hypertension?

Schäfer SG, Kaan EC, Christen MO, Löw-Kröger A, Mest HJ, Molderings GJ.

Ann N Y Acad Sci. 1995 Jul 12;763:659-72. Review.

PMID:
7677385
10.

Beta-adrenergic blocking drugs in severe heart failure.

Fowler M.

Rev Cardiovasc Med. 2002;3 Suppl 3:S20-6. Review.

PMID:
12447158
11.

Moxonidine: a new antiadrenergic antihypertensive agent.

Prichard BN, Graham BR, Owens CW.

J Hypertens Suppl. 1999 Aug;17(3):S41-54. Review.

PMID:
10489098
12.

The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications.

Triposkiadis F, Karayannis G, Giamouzis G, Skoularigis J, Louridas G, Butler J.

J Am Coll Cardiol. 2009 Nov 3;54(19):1747-62. doi: 10.1016/j.jacc.2009.05.015. Review.

13.

Moxonidine: a review of safety and tolerability after seven years of clinical experience.

Schachter M.

J Hypertens Suppl. 1999 Aug;17(3):S37-9. Review.

PMID:
10489097
14.

Effective antihypertensive therapy: blood pressure control with moxonidine.

Prichard BN, Graham BR.

J Cardiovasc Pharmacol. 1996;27 Suppl 3:S38-48. Review.

PMID:
8872298
16.

The use of beta-blockers in the treatment of chronic heart failure.

Rudisill PT, Kennedy C, Paul S.

Crit Care Nurs Clin North Am. 2003 Dec;15(4):439-46. Review.

PMID:
14717388

Supplemental Content

Support Center